In August 2022, we tested a number of substances of particular health concern. In addition to MDMA, a tablet submitted for analysis as ecstasy also contained the new psychoactive substance Clephedrone (4-CMC) identified. Another ecstasy tablet showed only a unknown substance was found. A sample submitted for analysis as ketamine instead contained 2-Fluorodeschloroketamine (2-FDCK). Synthetic cannabinoids were detected in two cannabis samples: one contained ADB-B-5Br-INACAanother a mixture of ADB-5Br-INACA, ADB-B-5Br-INACA, ADB-D-5Br-INACA. In addition Flualprazolam was identified instead of alprazolam in a XANAX sample.

In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 33-2022